Overview

Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
This study investigates the influence of two different insulin regimens, twice-daily insulin lispro low mix (LM) and once-daily insulin glargine, on perceived physical, mood, and cognitive symptoms as well as cognitive-motor task performance in patients with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
Protamines